Koru Pharma Co., Ltd. is a global biopharmaceutical company founded in 2016 specialising in medical aesthetic products for anti-ageing and skin rejuvenation. Today, the company is deeply committed to providing innovative cosmetological solutions that meet the highest standards of safety and efficacy while satisfying the needs of patients and practitioners. In a short time Koru Pharmaceuticals has become one of the major players in the Medical Aesthetics market with a global network of distributors and an extensive product portfolio available in more than 80 countries.We are committed to developing, manufacturing and commercialising innovation and pioneering medical solutions for corrective and aesthetic applications in dedication to humanity's quest for happier, more beautiful and quality lives. Koru Pharmaceuticals' global strategies are focused on the key principles of internal product development, strategic partnerships and select mergers/acquisitions of products, technologies and companies. We are committed to identifying opportunities that fit our capabilities, enhance our corporate goals and strengthen our competitive position as we expand our global pharmaceutical business.Global Presence & Distribution Network:Production & Supply: Seoul, South KoreaSales & Marketing: Kuala Lumpur, MalaysiaR&D Laboratory: Seoul, South Korea and San Francisco, USAManufacturing facility: Chuncheon, South KoreaLogistics Center: Kyvi, Ukraine and Guangzhou, ChinaExports: 6 continents; 80+ countriesAt A GlanceThe company has shown tremendous and continuous growth since its establishment. From its headquarters in Seoul, South Korea, Koru Pharmaceuticals has made its mark across the globe. A team of over 60 working tirelessly to generate approximately US$ 24 million in sales in 2022 from over 200 products.Product Portfolio: Anaesthetics, Biorevitalisation, Chemical Peelings, Cosmeceuticals, Fillers, Lipolytics, Microneedling, Placenta Injections, Threads